University of Maryland School of Medicine: Study Confirms Typhoid Vaccine Safety, Immune Response in Children
August 10, 2022
August 10, 2022
BALTIMORE, Maryland, Aug. 10 (TNSjou) -- The University of Maryland School of Medicine issued the following news:
* * *
Vaccine does not interfere with routine measles-rubella vaccine in Malawian children
* * *
A new study, published in The Lancet Global Health, finds the typhoid conjugate vaccine, Typbar TCV(R), provides immunity for up to three years in children as young as nine months old in Malawi. The research - conducted by the Blantyre M . . .
* * *
Vaccine does not interfere with routine measles-rubella vaccine in Malawian children
* * *
A new study, published in The Lancet Global Health, finds the typhoid conjugate vaccine, Typbar TCV(R), provides immunity for up to three years in children as young as nine months old in Malawi. The research - conducted by the Blantyre M . . .